Medtronic, Inc. Release: INFUSE® Bone Graft Receives Prestigious Prix Galien USA Award

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic (NYSE:MDT) announced today that INFUSE® Bone Graft, the company’s recombinant human bone morphogenetic protein technology, was honored with the Prix Galien USA 2008 Award for Best Biotechnology Product.